Impact of Early Valve Surgery on Outcome of Staphylococcus aureus Prosthetic Valve Infective Endocarditis: Analysis in the International Collaboration of Endocarditis–Prospective Cohort Study
Open Access
- 10 November 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 60 (5) , 741-749
Abstract
Background. The impact of early valve surgery (EVS) on the outcome of Staphylococcus aureus (SA) prosthetic valve infective endocarditis (PVIE) is unresolved. The objective of this study was to evaluate the association between EVS, performed within the first 60 days of hospitalization, and outcome of SA PVIE within the International Collaboration on Endocarditis–Prospective Cohort Study. Methods. Participants were enrolled between June 2000 and December 2006. Cox proportional hazards modeling that included surgery as a time-dependent covariate and propensity adjustment for likelihood to receive cardiac surgery was used to evaluate the impact of EVS and 1-year all-cause mortality on patients with definite left-sided S. aureus PVIE and no history of injection drug use. Results. EVS was performed in 74 of the 168 (44.3%) patients. One-year mortality was significantly higher among patients with S. aureus PVIE than in patients with non–S. aureus PVIE (48.2% vs 32.9%; P = .003). Staphylococcus aureus PVIE patients who underwent EVS had a significantly lower 1-year mortality rate (33.8% vs 59.1%; P = .001). In multivariate, propensity-adjusted models, EVS was not associated with 1-year mortality (risk ratio, 0.67 [95% confidence interval, .39–1.15]; P = .15). Conclusions. In this prospective, multinational cohort of patients with S. aureus PVIE, EVS was not associated with reduced 1-year mortality. The decision to pursue EVS should be individualized for each patient, based upon infection-specific characteristics rather than solely upon the microbiology of the infection causing PVIE.Keywords
This publication has 30 references indexed in Scilit:
- Preeminence of Staphylococcus aureus in Infective Endocarditis: A 1-Year Population-Based SurveyClinical Infectious Diseases, 2012
- Clinical course and predictors of death in prosthetic valve endocarditis over a 20-year periodThe Journal of Thoracic and Cardiovascular Surgery, 2010
- Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st CenturyArchives of internal medicine (1960), 2009
- Endocarditis Caused by Staphylococcus aureusMedicine, 2009
- Rationale, design, and methods for the early surgery in infective endocarditis study (ENDOVAL 1): A multicenter, prospective, randomized trial comparing the state-of-the-art therapeutic strategy versus early surgery strategy in infective endocarditisAmerican Heart Journal, 2008
- Management of Prosthetic Valve Infective EndocarditisThe American Journal of Cardiology, 2008
- Medical Versus Surgical Management of Staphylococcus aureus Prosthetic Valve EndocarditisThe American Journal of Medicine, 2006
- The use and effect of surgical therapy for prosthetic valve infective endocarditis: A propensity analysis of a multicenter, international cohortAmerican Heart Journal, 2005
- Staphylococcus aureus EndocarditisJAMA, 2005
- Editorial Response: The Role of Valve Replacement in the Treatment of Prosthetic Valve EndocarditisClinical Infectious Diseases, 1998